6814.TWO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
6814.TWOLukas Biomedical Inc.	$18.30	+0.00%	$766M	—
3118.TWOLevel Biotechnology Inc.	$31.40	-0.79%	$1.0B	—
4171.TWOGeneReach Biotechnology Corp.	$16.30	+0.93%	$934M	—
4186.TWOTaiwan Advance Bio-Pharmaceutical Inc.	$7.07	-1.81%	$636M	—
6236.TWONeith Corporation	$19.05	+0.00%	$794M	—
6810.TWOBio Preventive Medicine Corp.	$20.85	+0.24%	$1.0B	—
6827.TWOMegaPro Biomedical Co., Ltd	$11.30	-0.44%	$896M	—

Source: Financial Modeling Prep · peers by sector/industry

Lukas Biomedical Inc.

Founded in 2002 and headquartered in New Taipei, Taiwan, Lukas Biomedical Inc. primarily develops immune cell medical technologies. These innovations are utilized for regenerative medicine and as complementary treatments for cancer. The company's operations are segmented into four distinct areas: E-commerce, Medical Management Business, Cell Product, and Pharmaceutical Market. Furthermore, it diversifies its business by wholesaling and retailing cosmetics, alongside providing housing equipment rental services.

www.lukas-biomedical.com

Employees: 87
IPO / List date: Dec 31, 2020
HQ: TW

Held by traders on TradeandTell

No one on the platform currently holds 6814.TWO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in 6814.TWO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded 6814.TWO yet.